Following our observation of an EGFR mutation, a complementary immunohistochemical study was performed in order to rule out a diagnosis of bronchopulmonary carcinoma: the tumor cells did not expresss polyclonal AE1/AE3 cytokeratin, CK7, NapsinA, TTF1 or P40. The gene discussed is EGFR; the disease is neoplasm.